advanced search

INJECTION

ACCELERATING DEVELOPMENT OF SUBCUTANEOUS DELIVERY OF LARGE-VOLUME BIOLOGICS
WEARABLES
Thomas Mayer
Sonceboz
ACCELERATING DEVELOPMENT OF SUBCUTANEOUS DELIVERY OF LARGE-VOLUME BIOLOGICS
Tom Mayer discusses how Sonceboz’s vial-based on-body injector – the LVI-V – can expedite the launch of large-volume SC delivery of biologics by leveraging existing primary container technology, reducing associated risks and total cost of ownership.
KEY CONSIDERATIONS WHEN SPECIFYING A MOTION SYSTEM FOR WEARABLE INJECTORS
EXPERT VIEW
Dave Beckstoffer
KEY CONSIDERATIONS WHEN SPECIFYING A MOTION SYSTEM FOR WEARABLE INJECTORS
The reliable performance of a wearable drug delivery device is understandably paramount, so optimising the motion solution that drives it is crucial. Dave Beckstoffer discusses how best to achieve this and ensure the best match between the motion solution and the characteristics of the specified drug or drug range.
WEARABILITY AND USABILITY OF THE YPSODOSE 10 mL PATCH INJECTOR
WEARABLES
Dr Jakob Lange
Ypsomed
WEARABILITY AND USABILITY OF THE YPSODOSE 10 mL PATCH INJECTOR
Jakob Lange discusses the results of a recently published study into the usability and wearability of the YpsoDose 10 mL patch injector, providing a summary of the insights acquired during the study.
MIKRON AUTOMATION: A LEADER IN THE COMPLEX ASSEMBLY OF ON-BODY INJECTORS
WEARABLES
Jean-François Bauer
Mikron Automation
MIKRON AUTOMATION: A LEADER IN THE COMPLEX ASSEMBLY OF ON-BODY INJECTORS
Mikron Automation sets out its expertise in the assembly of on-body injectors, a field requiring exception precision and innovative approaches, as well as discussing how Mikron works with its partners from the very earliest stages of device development to help ensure projects are completed efficiently and successfully.
DRUG DELIVERY DEVICES THROUGHOUT THE DRUG DEVELOPMENT CYCLE
WEARABLES
Dr Ori Ben-David
Eitan Medical
DRUG DELIVERY DEVICES THROUGHOUT THE DRUG DEVELOPMENT CYCLE
Ori Ben-David discusses the considerations that must be made over the course of injectable drug development and how Eitan Medical’s Sapphire™ and Sorrel™ platforms offer pharmaceutical companies a full suite of device tools from early discovery through to commercialisation.
FLEXIBLE CARE – ENABLE WEARABLE DELIVERY
WEARABLES
Jennifer Estep
Enable Injections
FLEXIBLE CARE – ENABLE WEARABLE DELIVERY
Jennifer Estep and Mehul Desai discuss the benefits for patients and healthcare providers of innovative subcutaneous delivery.
USING MAGNETIC SENSORS FOR METERING DRUG VOLUME IN WEARABLE INJECTORS
WEARABLES
Tim Resker
Coto Technology
USING MAGNETIC SENSORS FOR METERING DRUG VOLUME IN WEARABLE INJECTORS
Tim Reskerdiscusses the application of tunnelling magnetoresistive sensing technology to on-body injectors, including the vital function of accurately measuring the delivered dose, as well as other functions, such as powering on the device.
FROM SIMULATION TO SPRING SATISFACTION
INDUSTRIALISATION
Drew Jelgerhuis
Scherdel Medtec
FROM SIMULATION TO SPRING SATISFACTION
Drew Jelgerhuis discusses the power of simulation to enhance a drug delivery device design project, including faster development times and reduced costs.
INDUSTRIALISATION OF PHARMACEUTICAL AND MEDICAL DEVICES IN THE SCIENTIFIC MOULDING APPROACH
INDUSTRIALISATION
Thomas Rudolph
Gerresheimer
INDUSTRIALISATION OF PHARMACEUTICAL AND MEDICAL DEVICES IN THE SCIENTIFIC MOULDING APPROACH
Thomas Rudolph, Markus Reil, Stefan Schumann and Tobias Weigert discuss Gerresheimer’s strategy for managing potential risks across the entire product lifecycle.
INDUSTRIALISATION AND SCALE-UP OF DRUG DELIVERY DEVICES
INDUSTRIALISATION
Dr Barry McDermott
West Pharmaceutical Services
INDUSTRIALISATION AND SCALE-UP OF DRUG DELIVERY DEVICES
Barry McDermott and Shari Krusniak look at the manufacturing processes involved in bringing a new drug delivery system and formulation to market.
EMBRACING OPPORTUNITIES PRESENTED BY DIGITALISATION: USING DATA TO DRIVE PERFORMANCE
INDUSTRIALISATION
Otto Abildgaard
Stevanato Group
EMBRACING OPPORTUNITIES PRESENTED BY DIGITALISATION: USING DATA TO DRIVE PERFORMANCE
Otto Abildgaard and Sebastian Berninger-Lund review the four-stage process Stevanato has developed to bring improvements in time to market through optimised manufacturing.
CONTINUOUS IMPROVEMENT: FROM ABSTRACTION TO REALITY
INDUSTRIALISATION
Tracy Pedreso
SHL Medical
CONTINUOUS IMPROVEMENT: FROM ABSTRACTION TO REALITY
Tracy Pedreso discusses SHL Medical’s strategy for making continuous improvement a reality.
SINGLE USE SYSTEMS – THE FUTURE OF BIOPHARMACEUTICAL PROCESSING
EXPERT VIEW
Jeff Lowe
SINGLE USE SYSTEMS – THE FUTURE OF BIOPHARMACEUTICAL PROCESSING
 Jeff Lowe considers single-use systems and looks at their role in the future of biopharmaceutical processing.
HOLISTIC DEVELOPMENT & INDUSTRIALISATION OF DRUG DELIVERY DEVICES & COMBINATION PRODUCTS
INDUSTRIALISATION
Mark Tunkel
Nemera
HOLISTIC DEVELOPMENT & INDUSTRIALISATION OF DRUG DELIVERY DEVICES & COMBINATION PRODUCTS
Mark Tunkel and Niyati Sapatnekar discuss Nemera’s holistic approach to development and industrialisation.
INTERVIEW: Piyush Agarwal, Tjoapack
INTERVIEW
Piyush Agarwal
INTERVIEW: Piyush Agarwal, Tjoapack
Piyush Agarwal talks with ONdrugDelivery about the current state of the injectable pharmaceuticals market and how working with a specialist contract packaging organisation can help pharma companies navigate their product through this rapidly evolving sector and deliver their product to market on time.
TURNING CONNECTED DRUG DELIVERY PIPE DREAMS INTO REALITY
CONNECTIVITY
Mindy Katz
TURNING CONNECTED DRUG DELIVERY PIPE DREAMS INTO REALITY
Mindy Katz discusses the benefits of integrating homecare technologies that are patient centric and connected.
MEETING AN UNMET PHARMA NEED: PIONEERING THE WAY TO A CONNECTED FUTURE
CONNECTIVITY
Chelsea Williams
SHL Medical
MEETING AN UNMET PHARMA NEED: PIONEERING THE WAY TO A CONNECTED FUTURE
Chelsea Williams, Nagisa Kobashi and Nils Weber discuss the digital transformation of injectables, where drug formulation and device are enmeshed within a connected ecosystem powered by patient data.
A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED CLINICAL TRIALS – THE HUMAN FACTORS RESULTS ARE IN!
CONNECTIVITY
Aurelie Pager
BD (Becton Dickinson & Company)
A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED CLINICAL TRIALS – THE HUMAN FACTORS RESULTS ARE IN!
 Aurélie Pager and Mircea Despa follow up on an article published in the December 2021 issue of ONdrugDelivery. BD has now completed a human factors study assessing the usability, acceptance and ease of use of its connected injection prototype for clinical trials.
PAVING THE WAY TO INTEGRATED DEVICE-DIGITAL SOLUTIONS
CONNECTIVITY
Dr Andreas Schneider
Ypsomed
PAVING THE WAY TO INTEGRATED DEVICE-DIGITAL SOLUTIONS
Andreas Schneider and Philippe Müller discuss the potential benefits and challenges of implementing connected device-digital solutions within the healthcare sector to improve the treatment of chronic conditions.
CONNECTING PATIENTS AND HEALTHCARE PROVIDERS IN THE AGE OF SELF-ADMINISTERED INJECTABLE DRUGS
CONNECTIVITY
Gemma Wood
Bespak
CONNECTING PATIENTS AND HEALTHCARE PROVIDERS IN THE AGE OF SELF-ADMINISTERED INJECTABLE DRUGS
Gemma Wood explores connected device development trends, the patient-centric benefits the technology has to offer and how, with the help of experienced manufacturing partners connected to key enabling technology partners, they can develop products that deliver improved patient outcomes.
CONNECTIVITY IN HEALTHCARE – FROM THE MILLENNIUM TO THE PANDEMIC AND BEYOND
EXPERT VIEW
Napoleon Monroe
CONNECTIVITY IN HEALTHCARE – FROM THE MILLENNIUM TO THE PANDEMIC AND BEYOND
Napoleon Monroe looks back at the factors that influenced the underwhelming uptake of connectivity-enabling technologies in the healthcare sector over the first two decades of the 21st century, how the covid-19 pandemic changed everything and what current healthcare challenges connectivity might solve.
PUTTING PROCESS ENGINEERING INTO ACTION
INJECTION
Jonathan Kearns
SHL Medical
PUTTING PROCESS ENGINEERING INTO ACTION
Jonathan Kearns and Kevin Huang consider how engineering competencies are being driven to the next level by leveraging process engineering and how this can transform drug-device projects.
PREMIUMCOAT<sup>®</sup> SOLUTIONS: HELPING CONTROL THE LEVEL OF SILICONE TO PROTECT SENSITIVE THERAPEUTICS
PREFILLED SYRINGES
Sebastien Cordier
Aptar Pharma
PREMIUMCOAT® SOLUTIONS: HELPING CONTROL THE LEVEL OF SILICONE TO PROTECT SENSITIVE THERAPEUTICS
Sébastien Cordier, Vincent Holterboch and Estelle Verger discuss how coated elastomer components, such as Aptar Pharma’s PremiumCoat®, can help drug developers optimise the balance between component processability and minimising silicone migration into a drug product.
IMPROVING CLINICAL OUTCOMES WITH A PATIENT-CENTRIC AND REUSABLE PEN PLATFORM
INJECTION
Cecile Gross
Nemera
IMPROVING CLINICAL OUTCOMES WITH A PATIENT-CENTRIC AND REUSABLE PEN PLATFORM
Cécile Gross and Radosław Romańczuk discuss Nemera’s Pendura AD pen platform and present case studies demonstrating how it can be tailored to address the user’s needs and meet pharma industry constraints.
Top